FRAMINGHAM – The Framingham Heart Study is suspending ALL in-person examinations of participants from March 13-27 as a precautionary measure to limit any potential exposure to COVID-19 and due to the voluntary nature of the exam.
There is no known or documented exposure to COVID-19 on the premises at this time, said the Framingham Heart Study.
[broadstreet zone=”59945″]
MetroWest Medical Center